Faruqi & Faruqi Encourages Investors in Picard Medical to Reach Out
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Feb 06 2026
0mins
Should l Buy PMI?
Source: PRnewswire
- Legal Investigation: Faruq & Faruqi is investigating potential claims against Picard Medical for securities purchased between September 2, 2025, and October 31, 2025, indicating possible legal risks that could undermine investor confidence in the company.
- Investor Contact Information: Investors who suffered losses during the specified period are encouraged to contact securities litigation partner Josh Wilson directly, with two provided phone numbers, reflecting the firm's commitment to supporting affected investors.
- Class Action Deadline: The firm reminds investors of the April 3, 2026, deadline to seek the role of lead plaintiff in the federal securities class action against Picard Medical, emphasizing the urgency for investors to act promptly.
- Market Impact: This investigation and potential class action could negatively affect Picard Medical's stock price, prompting investors to monitor developments closely to adjust their investment strategies and mitigate potential losses.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy PMI?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on PMI
About PMI
Picard Medical, Inc. is a holding company that owns a 100% interest in SynCardia Systems, LLC (SynCardia). SynCardia is a medical technology company that manufactures and sells the only United States Food and Drug Administration (FDA) and Health Canada-approved implantable total artificial heart (SynCardia TAH). The SynCardia TAH is a biventricular replacement device that consists of the SynCardia TAH implant, an external pneumatic driver that delivers precisely calibrated pulses of air to drive the implant, and drivelines that connect the driver to the implant. The SynCardia TAH implant is a system that consists of two independent artificial ventricles which are powered by an external pneumatic driver. Each artificial ventricle is made of a semi-rigid polyurethane housing and a rigid polyurethane base, with a four-layer flexible polyurethane diaphragm separating the blood chamber from the air chamber.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
Class Action Lawsuit Filed Against Picard Medical, Inc.
- Class Action Initiation: Picard Medical, Inc. (NYSE:PMI) faces a class action lawsuit for issuing false and misleading statements during the period from September 2 to October 31, 2025, affecting all investors who purchased shares, indicating a significant increase in legal risks for the company.
- Investor Rights Protection: The law firm Wolf Haldenstein Adler Freeman & Herz LLP, with over 125 years of experience in securities litigation, is committed to pursuing justice for investors harmed by the company's misrepresentations, showcasing the firm's expertise and dedication to investor rights.
- Lead Plaintiff Application Deadline: Investors must apply to be lead plaintiff by April 3, 2026, emphasizing the urgency for investors in the legal process, which may also impact the case's progression and outcome.
- Legal Consultation Call: The law firm encourages affected investors or those with relevant information to contact them to assist in the investigation, which not only aids the case's advancement but may also provide further legal support and protection for investors.
See More
Class Action Lawsuit Announced for Picard Medical, Inc.
- Class Action Initiation: Rosen Law Firm has announced a class action lawsuit against Picard Medical, Inc. (NYSE American: PMI) for securities purchasers between September 2 and October 31, 2025, indicating significant risk of losses for investors.
- Basis for Lawsuit: The lawsuit alleges that Picard Medical failed to disclose material adverse facts related to its business and securities trading during the class period, misleading investors and impacting the company's market reputation and stock price.
- Investor Rights Protection: Investors participating in the lawsuit are not required to pay any upfront fees, indicating that Rosen Law Firm provides protection for investors through a contingency fee arrangement, thereby enhancing investor confidence.
- Law Firm Background: Rosen Law Firm is renowned for its successful track record in securities class actions, having recovered over $438 million for investors in 2019 alone, showcasing its strong capabilities and influence in the legal field.
See More
Class Action Lawsuit Reminder Against Picard Medical, Inc.
- Class Action Notification: The Schall Law Firm reminds investors of a class action lawsuit against Picard Medical, Inc. (NYSE American:PMI) for violations of securities laws, with a class period from September 2, 2025, to October 31, 2025, urging investors to contact the firm before April 3, 2026, to participate.
- False Statement Allegations: The complaint alleges that Picard Medical made false and misleading statements to the market, engaging in a manipulation scheme to fraudulently inflate its stock price, resulting in investor losses when insiders sold shares at artificially inflated prices.
- Lack of Legal Representation: The class action has not yet been certified, meaning investors are not represented by an attorney until certification occurs, and those who choose not to act will remain absent class members, potentially losing their chance to recover losses.
- Investor Rights Protection: The Schall Law Firm specializes in securities class action lawsuits and shareholder rights litigation, encouraging affected investors to reach out for free consultations to discuss their rights and seek recovery of their losses.
See More
Class Actions Filed Against China Liberal Education and Picard Medical
- Class Action Initiated: Bragar Eagel & Squire, P.C. has filed class actions on behalf of shareholders against China Liberal Education Holdings Ltd. (OTCMKTS: CLEUF) and Picard Medical, Inc. (NYSE: PMI), indicating significant investor dissatisfaction with corporate governance and transparency.
- Serious Fraud Allegations: The lawsuit against China Liberal alleges illegal means of obtaining public listing value through a pump-and-dump scheme, resulting in over $300 million in investor losses, highlighting severe market concerns regarding the company's integrity.
- Stock Price Collapse: Picard Medical's stock price plummeted 70% on October 24, 2025, from $13.30 to $3.99 per share, and has since continued to decline to approximately $2.00, reflecting the company's vulnerability amid a crisis of investor confidence.
- Far-reaching Legal Consequences: The class actions faced by both companies could lead to substantial financial liabilities and impact their future fundraising capabilities and market reputation, prompting investors to closely monitor developments for potential risks.
See More
Multiple Companies Face Class Action Lawsuits
- Richtech Robotics Lawsuit: Richtech Robotics Inc. is accused of making false statements during the class period from January 27 to January 29, 2026, misleading investors about the company's prospects, with a lead plaintiff motion deadline of April 3, 2026.
- Plug Power Lawsuit: Plug Power, Inc. faces allegations of overstating the availability of DOE loan funds from January 17 to November 13, 2025, with investors needing to act by April 3, 2026, potentially impacting future project viability.
- Picard Medical Lawsuit: Picard Medical, Inc. is implicated in a fraudulent stock promotion scheme from September 2 to October 31, 2025, requiring investors to file a lead plaintiff motion by April 3, 2026, which may lead to stock price volatility.
- BlackRock TCP Lawsuit: BlackRock TCP Capital Corp. is accused of failing to timely value investments from November 6, 2024, to January 23, 2026, resulting in overstated NAV, with a lead plaintiff deadline of April 6, 2026.
See More
Picard Medical Faces Class Action for Securities Fraud
- Class Action Filed: Pomerantz LLP has announced a class action lawsuit against Picard Medical, alleging that the company and certain officers engaged in securities fraud or other unlawful business practices, with investors having until April 3, 2026, to apply as Lead Plaintiff.
- Stock Price Surge: Leading up to October 23, 2025, Picard's stock price skyrocketed from its IPO price of $4.00 to an all-time high of $13.68, despite the absence of any fundamental news, indicating irrational market behavior.
- Social Media Manipulation: Investigations revealed that Picard's stock was subject to an illicit social media promotion scheme, where impersonators posing as legitimate financial advisors made sensational but unfounded claims, creating a buying frenzy among retail investors.
- Severe Legal Consequences: Pomerantz LLP, a prominent firm in securities class litigation with a long history of recovering multimillion-dollar damages for victims, suggests that this case could have significant financial and reputational repercussions for Picard Medical.
See More
Class Action Lawsuit Filed Against Picard Medical, Inc.
- Class Action Initiation: Picard Medical, Inc. (NYSE:PMI) faces a class action lawsuit for issuing false and misleading statements during the period from September 2 to October 31, 2025, affecting all investors who purchased shares, indicating a significant increase in legal risks for the company.
- Investor Rights Protection: The law firm Wolf Haldenstein Adler Freeman & Herz LLP, with over 125 years of experience in securities litigation, is committed to pursuing justice for investors harmed by the company's misrepresentations, showcasing the firm's expertise and dedication to investor rights.
- Lead Plaintiff Application Deadline: Investors must apply to be lead plaintiff by April 3, 2026, emphasizing the urgency for investors in the legal process, which may also impact the case's progression and outcome.
- Legal Consultation Call: The law firm encourages affected investors or those with relevant information to contact them to assist in the investigation, which not only aids the case's advancement but may also provide further legal support and protection for investors.
See More
Class Action Lawsuit Announced for Picard Medical, Inc.
- Class Action Initiation: Rosen Law Firm has announced a class action lawsuit against Picard Medical, Inc. (NYSE American: PMI) for securities purchasers between September 2 and October 31, 2025, indicating significant risk of losses for investors.
- Basis for Lawsuit: The lawsuit alleges that Picard Medical failed to disclose material adverse facts related to its business and securities trading during the class period, misleading investors and impacting the company's market reputation and stock price.
- Investor Rights Protection: Investors participating in the lawsuit are not required to pay any upfront fees, indicating that Rosen Law Firm provides protection for investors through a contingency fee arrangement, thereby enhancing investor confidence.
- Law Firm Background: Rosen Law Firm is renowned for its successful track record in securities class actions, having recovered over $438 million for investors in 2019 alone, showcasing its strong capabilities and influence in the legal field.
See More
Class Action Lawsuit Reminder Against Picard Medical, Inc.
- Class Action Notification: The Schall Law Firm reminds investors of a class action lawsuit against Picard Medical, Inc. (NYSE American:PMI) for violations of securities laws, with a class period from September 2, 2025, to October 31, 2025, urging investors to contact the firm before April 3, 2026, to participate.
- False Statement Allegations: The complaint alleges that Picard Medical made false and misleading statements to the market, engaging in a manipulation scheme to fraudulently inflate its stock price, resulting in investor losses when insiders sold shares at artificially inflated prices.
- Lack of Legal Representation: The class action has not yet been certified, meaning investors are not represented by an attorney until certification occurs, and those who choose not to act will remain absent class members, potentially losing their chance to recover losses.
- Investor Rights Protection: The Schall Law Firm specializes in securities class action lawsuits and shareholder rights litigation, encouraging affected investors to reach out for free consultations to discuss their rights and seek recovery of their losses.
See More
Class Actions Filed Against China Liberal Education and Picard Medical
- Class Action Initiated: Bragar Eagel & Squire, P.C. has filed class actions on behalf of shareholders against China Liberal Education Holdings Ltd. (OTCMKTS: CLEUF) and Picard Medical, Inc. (NYSE: PMI), indicating significant investor dissatisfaction with corporate governance and transparency.
- Serious Fraud Allegations: The lawsuit against China Liberal alleges illegal means of obtaining public listing value through a pump-and-dump scheme, resulting in over $300 million in investor losses, highlighting severe market concerns regarding the company's integrity.
- Stock Price Collapse: Picard Medical's stock price plummeted 70% on October 24, 2025, from $13.30 to $3.99 per share, and has since continued to decline to approximately $2.00, reflecting the company's vulnerability amid a crisis of investor confidence.
- Far-reaching Legal Consequences: The class actions faced by both companies could lead to substantial financial liabilities and impact their future fundraising capabilities and market reputation, prompting investors to closely monitor developments for potential risks.
See More
Multiple Companies Face Class Action Lawsuits
- Richtech Robotics Lawsuit: Richtech Robotics Inc. is accused of making false statements during the class period from January 27 to January 29, 2026, misleading investors about the company's prospects, with a lead plaintiff motion deadline of April 3, 2026.
- Plug Power Lawsuit: Plug Power, Inc. faces allegations of overstating the availability of DOE loan funds from January 17 to November 13, 2025, with investors needing to act by April 3, 2026, potentially impacting future project viability.
- Picard Medical Lawsuit: Picard Medical, Inc. is implicated in a fraudulent stock promotion scheme from September 2 to October 31, 2025, requiring investors to file a lead plaintiff motion by April 3, 2026, which may lead to stock price volatility.
- BlackRock TCP Lawsuit: BlackRock TCP Capital Corp. is accused of failing to timely value investments from November 6, 2024, to January 23, 2026, resulting in overstated NAV, with a lead plaintiff deadline of April 6, 2026.
See More
Picard Medical Faces Class Action for Securities Fraud
- Class Action Filed: Pomerantz LLP has announced a class action lawsuit against Picard Medical, alleging that the company and certain officers engaged in securities fraud or other unlawful business practices, with investors having until April 3, 2026, to apply as Lead Plaintiff.
- Stock Price Surge: Leading up to October 23, 2025, Picard's stock price skyrocketed from its IPO price of $4.00 to an all-time high of $13.68, despite the absence of any fundamental news, indicating irrational market behavior.
- Social Media Manipulation: Investigations revealed that Picard's stock was subject to an illicit social media promotion scheme, where impersonators posing as legitimate financial advisors made sensational but unfounded claims, creating a buying frenzy among retail investors.
- Severe Legal Consequences: Pomerantz LLP, a prominent firm in securities class litigation with a long history of recovering multimillion-dollar damages for victims, suggests that this case could have significant financial and reputational repercussions for Picard Medical.
See More
